TrialDrug design, development and therapy2015

A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.

Yoichiro Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.